Literature DB >> 26062986

Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions at serotonin receptors may enhance downstream release of four pro-cognitive neurotransmitters.

Stephen M Stahl.   

Abstract

Vortioxetine is an antidepressant with multiple pharmacologic modes of action that enhance release of dopamine, norepinephrine, acetylcholine, and histamine.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26062986     DOI: 10.1017/S1092852915000358

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  3 in total

1.  Vortioxetine Improved Depressive State In Parkinson's Disease.

Authors:  Reiji Yoshimura; Atsuko Ikenouchi; Naomichi Okamoto; Yuki Konishi
Journal:  Cureus       Date:  2021-06-18

Review 2.  Assessment and Management of Cognitive and Psychosocial Dysfunctions in Patients With Major Depressive Disorder: A Clinical Review.

Authors:  Andrea Fiorillo; Bernardo Carpiniello; Serafino De Giorgi; Silvestro La Pia; Giuseppe Maina; Gaia Sampogna; Edoardo Spina; Alfonso Tortorella; Antonio Vita
Journal:  Front Psychiatry       Date:  2018-10-11       Impact factor: 4.157

Review 3.  Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research.

Authors:  Djamila Bennabi; Emmanuel Haffen; Vincent Van Waes
Journal:  Front Psychiatry       Date:  2019-11-06       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.